Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

NCT04492969 ·Status: UNKNOWN

Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer

NCT06301295 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy

NCT07119190 ·Status: NOT_YET_RECRUITING

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

NCT02202655 ·Status: UNKNOWN

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

NCT03059641 ·Status: COMPLETED

Circulating Tumor DNA in Surgical Lung Cancer Patients

NCT03081741 ·Status: UNKNOWN

A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

NCT03451526 ·Status: COMPLETED

Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients

NCT03664843 ·Status: UNKNOWN

99mTc-H7ND SPECT/CT Imaging in NSCLC

NCT05999214 ·Status: RECRUITING ·Phase: NA

Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy

NCT05636605 ·Status: RECRUITING

Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC

NCT05725915 ·Status: UNKNOWN

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

NCT06358222 ·Status: RECRUITING

Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function

NCT03357094 ·Status: UNKNOWN

Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer

NCT06572540 ·Status: RECRUITING ·Phase: NA

Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC

NCT00483015 ·Status: COMPLETED

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).

NCT03634826 ·Status: UNKNOWN

Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer

NCT06742021 ·Status: RECRUITING ·Phase: NA

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

NCT07166003 ·Status: RECRUITING

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

NCT05834413 ·Status: RECRUITING ·Phase: NA

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

NCT01517971 ·Status: COMPLETED

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC

NCT04886401 ·Status: RECRUITING

Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer

NCT05372081 ·Status: UNKNOWN

Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer

NCT02407912 ·Status: UNKNOWN ·Phase: NA

Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer

NCT02731001 ·Status: RECRUITING ·Phase: NA